Back

FSA-PIB AD

Official Title

Beta Amyloid PET Imaging for Alzheimer Disease: [18F]-Fluselenamyl (Alternative Vehicle) Comparison with [11C]-PIB (FSA-PIB AD)

Study Details

The purpose of this research study is to assess the sensitivity of a new radiotracer used in PET scan and compare with existing radiotracer in identifying amyloid plaques.

Principal Investigator

Dr. Tammie Benzinger

IRB Number

202310028

Eligibility

1. Participants must be at least 18 years old
2. Participants must not have electronic devices in their body
3. Participant must not have cognitive impairment or claustrophobia

Compensation is provided (contact the study team for compensation amount).

This study accepts healthy volunteers.

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back